How Depression Affects The Brain - Yale Medicine Explains

Updated on: July 25,2024

How Depression Affects The Brain - Yale Medicine Explains

Updated on:July 25,2024

New insight into role of amyloid beta in Alzheimer's disease

by Tamara Bhandari,Washington University School of Medicine in St. LouisA new technique for measuring levels in the brain of amyloid beta, a key protein associated with Alzheimer’s disease, woul

Updated on: April 02,2024

New insight into role of amyloid beta in Alzheimer's disease

by Tamara Bhandari,Washington University School of Medicine in St. LouisA new technique for measuring levels in the brain of amyloid beta, a key protein associated with Alzheimer’s disease, woul

Updated on:April 02,2024

Multi-omics analysis identifies molecularly defined Alzheimer's disease subtypes

by Jacqueline Mitchell,Beth Israel Deaconess Medical CenterStudy design. Credit:PLOS Biology(2024). DOI: 10.1371/journal.pbio.3002607Omics analysis is the process of analyzing large

Updated on: June 15,2024

Multi-omics analysis identifies molecularly defined Alzheimer's disease subtypes

by Jacqueline Mitchell,Beth Israel Deaconess Medical CenterStudy design. Credit:PLOS Biology(2024). DOI: 10.1371/journal.pbio.3002607Omics analysis is the process of analyzing large

Updated on:June 15,2024

Gantenerumab does not slow clinical decline in early Alzheimer disease, research finds

by Elana GotkineThe use of gantenerumab leads to lower amyloid plaque burden at 116 weeks, but is not associated with slower clinical decline among patients with early Alzheimer disease, according to

Updated on: February 24,2024

Gantenerumab does not slow clinical decline in early Alzheimer disease, research finds

by Elana GotkineThe use of gantenerumab leads to lower amyloid plaque burden at 116 weeks, but is not associated with slower clinical decline among patients with early Alzheimer disease, according to

Updated on:February 24,2024

Experimental therapy eases Alzheimer's signs, symptoms in mice

by Carole Tanzer MillerA new cellular therapy improved learning and memory in mice with Alzheimer's disease, researchers report.The therapy—developed at the University of Nebraska Medical Center (

Updated on: February 24,2024

Experimental therapy eases Alzheimer's signs, symptoms in mice

by Carole Tanzer MillerA new cellular therapy improved learning and memory in mice with Alzheimer's disease, researchers report.The therapy—developed at the University of Nebraska Medical Center (

Updated on:February 24,2024

Research into the nature of memory reveals how cells that store information are stabilized over time

byUniversity at BuffaloDheeraj Roy, Ph.D., assistant professor in the Department of Physiology and Biophysics in the Jacobs School of Medicine and Biomedical Sciences at UB, is a senior author o

Updated on: April 09,2024

Research into the nature of memory reveals how cells that store information are stabilized over time

byUniversity at BuffaloDheeraj Roy, Ph.D., assistant professor in the Department of Physiology and Biophysics in the Jacobs School of Medicine and Biomedical Sciences at UB, is a senior author o

Updated on:April 09,2024

Over 7 million US seniors have mental declines that threaten financial skills

by Alan MozesAs Americans age, millions end up struggling with dementia or some level of memory impairment and diminished capacity to think clearly and make decisions.Yet a new study says that despite

Updated on: May 05,2024

Over 7 million US seniors have mental declines that threaten financial skills

by Alan MozesAs Americans age, millions end up struggling with dementia or some level of memory impairment and diminished capacity to think clearly and make decisions.Yet a new study says that despite

Updated on:May 05,2024

FDA approves Vyalev for advanced Parkinson's disease

by Lori SolomonThe U.S. Food and Drug Administration has approved AbbVie's Vyalev (foscarbidopa and foslevodopa) for adults living with advanced Parkinson's disease (PD).Vyalev is the first an

Updated on: November 07,2024

FDA approves Vyalev for advanced Parkinson's disease

by Lori SolomonThe U.S. Food and Drug Administration has approved AbbVie's Vyalev (foscarbidopa and foslevodopa) for adults living with advanced Parkinson's disease (PD).Vyalev is the first an

Updated on:November 07,2024

Study links long-term consumption of reused deep-fried oil with increased neurodegeneration

byAmerican Society for Biochemistry and Molecular BiologyCredit: Pixabay/CC0 Public DomainA new study found higher levels of neurodegeneration in rats that consumed reused deep-fried cooking oil

Updated on: March 28,2024

Study links long-term consumption of reused deep-fried oil with increased neurodegeneration

byAmerican Society for Biochemistry and Molecular BiologyCredit: Pixabay/CC0 Public DomainA new study found higher levels of neurodegeneration in rats that consumed reused deep-fried cooking oil

Updated on:March 28,2024

New memory drug moves into Phase 1 clinical study

by National Institutes of HealthAn experimental drug that may improve memory is now being tested in a Phase 1 safety trial. The compound, BPN14770, was developed by Tetra Discovery Partners, with

Updated on: February 27,2024

New memory drug moves into Phase 1 clinical study

by National Institutes of HealthAn experimental drug that may improve memory is now being tested in a Phase 1 safety trial. The compound, BPN14770, was developed by Tetra Discovery Partners, with

Updated on:February 27,2024

Obesity linked to neurodegeneration through insulin resistance

byPublic Library of ScienceSugarfly. Artistic rendering generated by DALL.E the prompt used is "The drawing of the fruit fly Drosophila in a dark background in the style of Seurat." Th

Updated on: January 10,2024

Obesity linked to neurodegeneration through insulin resistance

byPublic Library of ScienceSugarfly. Artistic rendering generated by DALL.E the prompt used is "The drawing of the fruit fly Drosophila in a dark background in the style of Seurat." Th

Updated on:January 10,2024

Photostimulation of lymphatic clearance of β-amyloid: A new strategy for Alzheimer's disease therapy

by Higher Education PressPhotostimulation-induced stimulation of lymphatic clearance of Aβ from the brain in 5xFAD mice. Credit: Dongyu Li, Hao Lin, Silin Sun, Shaojun Liu, Zhang Liu, Yuening He, Jing

Updated on: February 24,2024

Photostimulation of lymphatic clearance of β-amyloid: A new strategy for Alzheimer's disease therapy

by Higher Education PressPhotostimulation-induced stimulation of lymphatic clearance of Aβ from the brain in 5xFAD mice. Credit: Dongyu Li, Hao Lin, Silin Sun, Shaojun Liu, Zhang Liu, Yuening He, Jing

Updated on:February 24,2024